The aim of this study was to elucidate the research direction and application value of neutrophil-to-lymphocyte ratio (NLR) as an emerging inflammatory marker in rheumatoid arthritis (RA) from both literature and clinical perspectives. Firstly, we made an extensive analysis in terms of the number of publications, highly cited literature, co-cited references, and keywords. Subsequently, a retrospective exploration of clinical data of 1490 patients with rheumatic diseases admitted to the First Affiliated Hospital of Anhui University of Chinese Medicine was conducted. Logistic regression models were used to explore the independent predictive role of NLR in different scenarios. Nomogram was developed and the model was clinically evaluated by recipient operating characteristic (ROC) curves, calibration plots and decision curve analysis. In addition, association rule analysis and Mantel test were used to determine associations between NLR and clinical characteristics and self-perception of patients. A total of 544 articles were retrieved, focusing on the pathophysiology and clinical studies of RA-NLR, such as “disease activity,” “inflammation” and “classification.” Retrospective analysis demonstrated that NLR, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels were significantly higher in RA patients than in non-RA patients. Logistic regression models identified gender, age, NLR, ESR and CRP as independent predictors of RA. The ROC curve determined a cutoff value of 2.258 for NLR and a maximum area under the curve of 0.736. Both association rule analysis and Mantel test showed that NLR was highly correlated with inflammatory markers such as ESR, CRP, and self-perception scale scores before and after treatment. NLR > 2.258 was a meaningful risk factor for moderate-to-severe pain and higher disease activity, which predictive reliability was further confirmed in subgroup stratification analyses. NLR, as a novel inflammatory marker, correlates with clinical characteristics and self-perception of RA patients, acting as an independent predictor of RA diagnosis and activity assessment.
1 February 2024 in International Journal of General Medicine
Objective: This study aimed to evaluate the effect of traditional Chinese medicine (TCM) on endpoint events in patients with gouty arthritis (GA). Methods and Materials: A total of 2091 hospitalized GA patients were followed up by telephone, and propensity score matching (PSM) was used to reduce potential bias in the study design. Cox proportional risk model and Kaplan-Meier survival curve were utilized to analyze the impact and time effect of factors on the readmission of GA patients. The differences of laboratory indexes before and after treatment between the low and high exposure groups were compared, and the types and frequencies of medicines in all patients were counted. Association rule analysis was performed to investigate the association between TCM and test indexes or endpoint events. Results: After 1:1 PSM, 187 patients were enrolled in the TCM group and 187 patients in the non-TCM group. The incidence of readmission, new tophus, and all-cause death was lower in the TCM group than that in the non-TCM group (P < 0.05). Cox proportional risk regression analysis showed that TCM, NSAIDs and uric acid lowering drug were independent protective factors for GA readmission. The protective effect was enhanced by the prolongation of TCM treatment and the drug combinations. Kaplan-Meier survival curves indicated a significantly lower readmission rate in the high exposure group than in the low exposure group (P < 0.01). Compared with before treatment, NLR, hs-CRP, UA, TC and other laboratory indexes of the low and high exposure groups were improved after treatment (P < 0.01); The improvement of TG and TC in the high exposure group was more significant than the low exposure group (P < 0.01). The analysis of medicines used by all patients identified the top 20 Chinese herbal medicines and the top 2 Chinese patent medicines. The core drugs identified through association rule analysis that can improve test index and reduce the incidence of endpoint events include Yiyiren, Danshen, and HQC, among others. The network diagram of association rule analysis intuitively shows the relationship between core drugs and “improvement of indicators” and “the absence of endpoint events”. Conclusion: TCM is associated with a reduced incidence of endpoint events in patients with GA.
1 December 2024 in Journal of Inflammation Research
Rheumatoid arthritis (RA) is characterized by chronic inflammation and autoimmunity. Moreover, the disease activity, co-morbidities, and prognosis of RA are closely associated with changes in red blood cell (RBC)-related parameters. The role of these parameters in RA has therefore been extensively studied. Accordingly, this article summarizes and analyzes the close relationship of RBC-related parameters such as RBC count, hemoglobin, and RBC distribution width with disease activity, co-morbidities, and prognosis in RA by reviewing the available literature. In addition, given the immunomodulatory functions of RBCs, their surface proteins, contents, and microparticles are involved in the immunomodulatory process during RA. Overall, this review aims to assess the important clinical value and immunological significance of RBCs and their related parameters in the monitoring and management of RA, thus providing a reference for the clinical diagnosis and treatment of RA and the direction for the research on RBC-related immunity.
This study aimed to investigate the effect of traditional Chinese medicine (TCM) intervention on the risk of readmission and laboratory indicators in patients with rheumatoid arthritis hypercoagulable state. In the retrospective cohort design, patients with RA hospitalized between June 2013 and June 2021 at the First Affiliated Hospital of Anhui University of Chinese Medicine were followed up by telephone. Propensity score matching (PSM) was used to balance deviations in baseline information between patients in the hypercoagulable (HC) and non-hypercoagulable (Non-HC) groups, with exposure defined as receiving TCM treatment for ≥ 1 month. Cox proportional hazards model and Kaplan–Meier survival curves were employed to determine the factors influencing the readmission of RA-HC patients. Mantel test and association rule analysis was used to explore the relationship between the included factors and laboratory indicators. A total of 1169 cases were successfully followed up, including 831 RA-HC patients. 1:2 PSM yielded 311 patients in the non-HC group versus 535 patients in the HC group. We observed that the incidence of readmission and surgical treatment was significantly higher in the HC group than in the non-HC group, while the incidence of readmission, surgical treatment, and all-cause mortality was much lower in the exposed group than in the non-exposed group (all P < .05). Based on the Cox proportional risk model, we identified age above 60 years, Sjogren’s syndrome, neutrophil count, and neutrophil-lymphocyte ratio (NLR) as risk factors for readmission, with TCM playing a protective role. The Kaplan–Meier survival curves further showed that the risk of readmission in the high-exposure subgroup was markedly lower than that of the low-exposure subgroup. Furthermore, the Mantel test highlights an intrinsic correlation between coagulation markers and other markers such as erythrocyte sedimentation rate (ESR) and hypersensitive c-reactive protein (hs-CRP), which are dramatically influenced by gender, age, etc. In addition, association rule analysis revealed a strong correlation between TCM and non-readmission, as well as improvement in rheumatoid factor, hs-CRP, ESR, platelet count, and NLR in RA-HC patients. As a promising therapeutic strategy, TCM with sufficient intensity and duration interventions can effectively reduce the risk of readmission and relieve laboratory indicators in RA-HC patients.